LY379196

CAS No. 737736-10-6

LY379196( LY 379196 )

Catalog No. M15820 CAS No. 737736-10-6

LY379196 is a highly specific PKCβ inhibitor with IC50 of 30-50 nM for PKCβI and PKCβII.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    LY379196
  • Note
    Research use only, not for human use.
  • Brief Description
    LY379196 is a highly specific PKCβ inhibitor with IC50 of 30-50 nM for PKCβI and PKCβII.
  • Description
    LY379196 is a highly specific PKCβ inhibitor with IC50 of 30-50 nM for PKCβI and PKCβII, displays >10-fold selectivity of PKCα, δ, η, and γ (>600 nM); blocks TPA-induced monocytic differentiation of HL60 cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    LY 379196
  • Pathway
    Angiogenesis
  • Target
    PKC
  • Recptor
    PKC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    737736-10-6
  • Formula Weight
    ——
  • Molecular Formula
    C29H30N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    (12E,32E,6S)-6-((dimethylamino)methyl)-22,25-dihydro-11H,21H,31H-1,3(3,1)-diindola-2(3,4)-pyrrolacyclononaphane-22,25-dione

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Jirousek MR, et al. J Med Chem. 1996 Jul 5;39(14):2664-71. 2. Slosberg ED, et al. Mol Carcinog. 2000 Mar;27(3):166-76. 3. Tabit CE, et al. Circulation. 2013 Jan 1;127(1):86-95.
molnova catalog
related products
  • ζ-Stat

    ζ-Stat (1,3,6-Naphthalenetrisulfonic acid) is a novel PKC-zeta (PKC-ζ) specific inhibitor with IC50 of 5 uM.

  • Hispidin

    Hispidin is a polyphenol originally including antioxidant anti-inflammatory and cytoprotective properties.

  • Bisindolylmaleimide ...

    Bisindolylmaleimide X hydrochloride (BIM-X hydrochloride) is a potent and selective PKC inhibitor and a CDK2 antagonist with an IC50 of 200 nM.